3-rx.comCustomer Support3-rx.com
Find a product
    HomeAbout UsFAQContactHelp
 
   
 
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics
Online Pharmacy



Type 2 diabetes mellitus, more often known as type 2 diabetes, is the most common type of diabetes


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer - Stroke -

Researchers Draft 3-D Protein Map to Aid Stroke, Cancer Research

Cancer • • StrokeJun 26, 09

A new three-dimensional computer protein map is helping researchers at the University of Alabama at Birmingham (UAB) unravel the biological pathways that control brain-cell death after a stroke.

The new map will help identify new drug targets and test compounds to slow brain-cell death, halt brain cancer and improve pain control, the study authors said. The findings are published online in the Journal of Biological Chemistry.

Starting with known cell coordinates, biological structures and other data, UAB researchers focused on a protein called acid-sensing ion channel-1, or ASIC-1. This protein acts as a gateway on the surface of brain cells called neurons. The researchers generated a 3-D computer map of ASIC-1, which greatly simplifies the testing of any drug or compound designed to protect neurons, regulate their molecular interactions or isolate brain tumors.

“This protein ASIC-1 has a lot of little nooks and crevices where other molecules can sit and interact with the channel,” said Yawar Qadri, a graduate student in the UAB Department of Physiology and Biophysics and the study’s lead author. “With the map we’ve generated and the area we’ve described, researchers can fine-tune their ideas and tailor experimental compounds.”

Dale Benos, Ph.D., chair of the Department of Physiology and Biophysics and a co-author on the study, said the ASIC-1 map is an invaluable tool in the ongoing search for new drugs that will specifically act on this biological pathway.

“The hope is that when a person has a stroke or they get diagnosed with a brain tumor, the patient can be given a drug that will keep his or her neurons alive and functioning longer, or we can keep cancer from migrating further,” Benos said.

The study began with a toxin found only in the venom of the Trinidad chevron tarantula. In earlier laboratory research, this venom toxin proved capable of slowing neuronal death, inhibiting cancer growth and improving other biological disorders. UAB researchers wanted to simplify the search for non-venom agents that interact with ASIC-1 for positive results.

Qadri and his UAB colleagues generated the map of ASIC-1 with a software program called Modeller, developed by engineers at the University of California, San Francisco. The UAB ASIC-l map study includes validation work confirming its accuracy.

Source: University of Alabama at Birmingham



Print Version
Tell-a-Friend

RELATED ARTICLES:
  Obesity and Colon Cancer a Deadly Combination
  Red Meat, Obesity Raise the Risk of Colon Cancer
  LSUHSC researcher finds first inherited prostate cancer genetic mutation in African-American men
  Novel stroke treatment passes safety stage of UCI-led clinical trial
  Different strokes help tissue heal
  Cellular Communication in the Cancer Microenvironment
  Cell-Enriched Fat Grafts Improve Long-Term Graft Retention in Breast Reconstructive Surgery
  Exercise can lower breast cancer risk
  Vitamin D Halts Growth of Breast Cancer Tumors
  Metastatic Breast Cancer: Causes, Symptoms And Treatment
  Aspirin May Boost Breast Cancer Survival
  International Conference for Young Women Affected by Breast Cancer Reaches 10 Year Milestone

 


Advertisement
















Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site